20 Recruiting Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Metastatic Pancreatic Ductal Adenocarcinoma
Related Conditions
Top Recruiting Metastatic Pancreatic Ductal Adenocarcinoma Studies
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
📍 Memorial Sloan Kettering Monmouth (All protocol activities) — Middletown, New Jersey
View Study & Checklist ➔Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
📍 Cedars-Sinai Cancer at SOCC — Los Angeles, California
View Study & Checklist ➔MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Chicago Medical Center /ID# 279460 — Chicago, Illinois
View Study & Checklist ➔Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔